JP2006518763A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2006518763A5 JP2006518763A5 JP2006503856A JP2006503856A JP2006518763A5 JP 2006518763 A5 JP2006518763 A5 JP 2006518763A5 JP 2006503856 A JP2006503856 A JP 2006503856A JP 2006503856 A JP2006503856 A JP 2006503856A JP 2006518763 A5 JP2006518763 A5 JP 2006518763A5
- Authority
- JP
- Japan
- Prior art keywords
- nitro
- phenyl
- alkyl
- phenoxy
- compound according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 150000001875 compounds Chemical class 0.000 claims 71
- -1 C 1 to 4 alkylureyl Chemical group 0.000 claims 65
- 125000000217 alkyl group Chemical group 0.000 claims 39
- 125000001072 heteroaryl group Chemical group 0.000 claims 27
- 229910052736 halogen Inorganic materials 0.000 claims 25
- 125000003545 alkoxy group Chemical group 0.000 claims 24
- 150000002367 halogens Chemical class 0.000 claims 21
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 21
- 125000002887 hydroxy group Chemical group [H]O* 0.000 claims 18
- 125000004093 cyano group Chemical group *C#N 0.000 claims 17
- 125000001188 haloalkyl group Chemical group 0.000 claims 17
- 125000002252 acyl group Chemical group 0.000 claims 15
- 125000005392 carboxamide group Chemical class NC(=O)* 0.000 claims 14
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 claims 13
- 125000004414 alkyl thio group Chemical group 0.000 claims 12
- 125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 claims 12
- 125000004390 alkyl sulfonyl group Chemical group 0.000 claims 11
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 claims 11
- 125000004438 haloalkoxy group Chemical group 0.000 claims 11
- 125000001424 substituent group Chemical group 0.000 claims 11
- 125000005432 dialkylcarboxamide group Chemical group 0.000 claims 9
- 125000004423 acyloxy group Chemical group 0.000 claims 8
- 125000005431 alkyl carboxamide group Chemical group 0.000 claims 8
- 125000004644 alkyl sulfinyl group Chemical group 0.000 claims 8
- 125000004767 (C1-C4) haloalkoxy group Chemical group 0.000 claims 7
- 229910052799 carbon Inorganic materials 0.000 claims 7
- 229910052739 hydrogen Inorganic materials 0.000 claims 7
- 125000004765 (C1-C4) haloalkyl group Chemical group 0.000 claims 6
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 claims 6
- 125000004441 haloalkylsulfonyl group Chemical group 0.000 claims 6
- 125000004995 haloalkylthio group Chemical group 0.000 claims 6
- 150000003839 salts Chemical class 0.000 claims 6
- SNOOUWRIMMFWNE-UHFFFAOYSA-M sodium;6-[(3,4,5-trimethoxybenzoyl)amino]hexanoate Chemical compound [Na+].COC1=CC(C(=O)NCCCCCC([O-])=O)=CC(OC)=C1OC SNOOUWRIMMFWNE-UHFFFAOYSA-M 0.000 claims 6
- 239000012453 solvate Substances 0.000 claims 6
- 229910052717 sulfur Inorganic materials 0.000 claims 6
- 238000011282 treatment Methods 0.000 claims 6
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 claims 5
- 125000005422 alkyl sulfonamido group Chemical group 0.000 claims 5
- 125000000753 cycloalkyl group Chemical group 0.000 claims 5
- 125000000623 heterocyclic group Chemical group 0.000 claims 5
- 150000004677 hydrates Chemical class 0.000 claims 5
- 238000000034 method Methods 0.000 claims 5
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims 4
- 125000000304 alkynyl group Chemical group 0.000 claims 4
- 206010012601 diabetes mellitus Diseases 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 125000004440 haloalkylsulfinyl group Chemical group 0.000 claims 4
- 125000004200 2-methoxyethyl group Chemical group [H]C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 3
- VGGSQFUCUMXWEO-UHFFFAOYSA-N Ethene Chemical group C=C VGGSQFUCUMXWEO-UHFFFAOYSA-N 0.000 claims 3
- 239000005977 Ethylene Substances 0.000 claims 3
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 claims 3
- 125000003282 alkyl amino group Chemical group 0.000 claims 3
- 125000004391 aryl sulfonyl group Chemical group 0.000 claims 3
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 claims 3
- 125000000392 cycloalkenyl group Chemical group 0.000 claims 3
- 125000001511 cyclopentyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 3
- 125000004663 dialkyl amino group Chemical group 0.000 claims 3
- 238000004519 manufacturing process Methods 0.000 claims 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 3
- 229910052757 nitrogen Inorganic materials 0.000 claims 3
- 238000011321 prophylaxis Methods 0.000 claims 3
- 125000000168 pyrrolyl group Chemical group 0.000 claims 3
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 claims 3
- 229920002554 vinyl polymer Polymers 0.000 claims 3
- 125000004769 (C1-C4) alkylsulfonyl group Chemical group 0.000 claims 2
- 125000004771 (C1-C4) haloalkylsulfinyl group Chemical group 0.000 claims 2
- 125000000143 2-carboxyethyl group Chemical group [H]OC(=O)C([H])([H])C([H])([H])* 0.000 claims 2
- 125000004801 4-cyanophenyl group Chemical group [H]C1=C([H])C(C#N)=C([H])C([H])=C1* 0.000 claims 2
- 125000004172 4-methoxyphenyl group Chemical group [H]C1=C([H])C(OC([H])([H])[H])=C([H])C([H])=C1* 0.000 claims 2
- 125000003601 C2-C6 alkynyl group Chemical group 0.000 claims 2
- 208000032928 Dyslipidaemia Diseases 0.000 claims 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims 2
- 208000035150 Hypercholesterolemia Diseases 0.000 claims 2
- 208000031226 Hyperlipidaemia Diseases 0.000 claims 2
- 206010022489 Insulin Resistance Diseases 0.000 claims 2
- 208000017170 Lipid metabolism disease Diseases 0.000 claims 2
- 208000001145 Metabolic Syndrome Diseases 0.000 claims 2
- 201000000690 abdominal obesity-metabolic syndrome Diseases 0.000 claims 2
- 239000002253 acid Substances 0.000 claims 2
- 125000003342 alkenyl group Chemical group 0.000 claims 2
- 125000004422 alkyl sulphonamide group Chemical group 0.000 claims 2
- 125000003118 aryl group Chemical group 0.000 claims 2
- 125000001246 bromo group Chemical group Br* 0.000 claims 2
- 125000001309 chloro group Chemical group Cl* 0.000 claims 2
- 125000005363 dialkylsulfonamide group Chemical group 0.000 claims 2
- 239000003937 drug carrier Substances 0.000 claims 2
- 125000004494 ethyl ester group Chemical group 0.000 claims 2
- 125000001153 fluoro group Chemical group F* 0.000 claims 2
- 239000008103 glucose Substances 0.000 claims 2
- 125000002349 hydroxyamino group Chemical group [H]ON([H])[*] 0.000 claims 2
- 201000001421 hyperglycemia Diseases 0.000 claims 2
- 208000006575 hypertriglyceridemia Diseases 0.000 claims 2
- 125000002962 imidazol-1-yl group Chemical group [*]N1C([H])=NC([H])=C1[H] 0.000 claims 2
- 208000030159 metabolic disease Diseases 0.000 claims 2
- 125000001715 oxadiazolyl group Chemical group 0.000 claims 2
- 229910052760 oxygen Inorganic materials 0.000 claims 2
- 230000002265 prevention Effects 0.000 claims 2
- 125000003226 pyrazolyl group Chemical group 0.000 claims 2
- 125000004076 pyridyl group Chemical group 0.000 claims 2
- 208000011580 syndromic disease Diseases 0.000 claims 2
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims 2
- 208000001072 type 2 diabetes mellitus Diseases 0.000 claims 2
- 230000004584 weight gain Effects 0.000 claims 2
- 235000019786 weight gain Nutrition 0.000 claims 2
- 125000004504 1,2,4-oxadiazolyl group Chemical group 0.000 claims 1
- YPXRIOYBDVXGIO-UHFFFAOYSA-N 1-[1-[6-(4-acetylphenoxy)-3-nitropyridin-2-yl]piperidin-4-yl]ethanone Chemical compound C1CC(C(=O)C)CCN1C1=NC(OC=2C=CC(=CC=2)C(C)=O)=CC=C1[N+]([O-])=O YPXRIOYBDVXGIO-UHFFFAOYSA-N 0.000 claims 1
- UYZMRNXBHUIYIL-UHFFFAOYSA-N 1-[4-[3-[4-(methoxymethyl)piperidin-1-yl]-4-nitrophenoxy]phenyl]ethanone Chemical compound C1CC(COC)CCN1C1=CC(OC=2C=CC(=CC=2)C(C)=O)=CC=C1[N+]([O-])=O UYZMRNXBHUIYIL-UHFFFAOYSA-N 0.000 claims 1
- FMLOEBLGSXIREX-UHFFFAOYSA-N 1-[4-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]butan-1-one Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=CC(=CC=2)C(=O)CCC)=CC=C1[N+]([O-])=O FMLOEBLGSXIREX-UHFFFAOYSA-N 0.000 claims 1
- DBULFMSJWWTZHT-UHFFFAOYSA-N 1-[4-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]ethanone Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=CC(=CC=2)C(C)=O)=CC=C1[N+]([O-])=O DBULFMSJWWTZHT-UHFFFAOYSA-N 0.000 claims 1
- PZJDKUSWONJXFN-UHFFFAOYSA-N 1-[4-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]hexan-1-one Chemical compound C1=CC(C(=O)CCCCC)=CC=C1OC1=CC=C([N+]([O-])=O)C(N2CCC(CCC)CC2)=C1 PZJDKUSWONJXFN-UHFFFAOYSA-N 0.000 claims 1
- UDUBLFGDNOWYFL-UHFFFAOYSA-N 1-[4-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]pentan-1-one Chemical compound C1=CC(C(=O)CCCC)=CC=C1OC1=CC=C([N+]([O-])=O)C(N2CCC(CCC)CC2)=C1 UDUBLFGDNOWYFL-UHFFFAOYSA-N 0.000 claims 1
- QGCMNWAITFFWRS-UHFFFAOYSA-N 1-[4-[4-nitro-3-(4-pyridin-2-ylsulfanylpiperidin-1-yl)phenoxy]phenyl]ethanone Chemical compound C1=CC(C(=O)C)=CC=C1OC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)SC=2N=CC=CC=2)=C1 QGCMNWAITFFWRS-UHFFFAOYSA-N 0.000 claims 1
- FABWZDHUYWQDKR-UHFFFAOYSA-N 1-[5-(4-ethenylphenoxy)-2-nitrophenyl]-4-propylpiperidine Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=CC(C=C)=CC=2)=CC=C1[N+]([O-])=O FABWZDHUYWQDKR-UHFFFAOYSA-N 0.000 claims 1
- BZQSVOJMQLADPO-UHFFFAOYSA-N 2-[1-[2-nitro-5-[4-(1,2,4-triazol-1-yl)phenoxy]phenyl]piperidin-4-yl]sulfanylpyridine Chemical compound C1=C(N2CCC(CC2)SC=2N=CC=CC=2)C([N+](=O)[O-])=CC=C1OC(C=C1)=CC=C1N1C=NC=N1 BZQSVOJMQLADPO-UHFFFAOYSA-N 0.000 claims 1
- BNHXXPBMPCCDAX-UHFFFAOYSA-N 2-[1-[5-(4-methylsulfonylphenoxy)-2-nitrophenyl]piperidin-4-yl]sulfanylpyridine Chemical compound C1=CC(S(=O)(=O)C)=CC=C1OC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)SC=2N=CC=CC=2)=C1 BNHXXPBMPCCDAX-UHFFFAOYSA-N 0.000 claims 1
- YVCMBGPPTCBEDP-UHFFFAOYSA-N 2-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]-5-(trifluoromethyl)pyridine Chemical compound C1CC(CCC)CCN1C1=CC(OC=2N=CC(=CC=2)C(F)(F)F)=CC=C1[N+]([O-])=O YVCMBGPPTCBEDP-UHFFFAOYSA-N 0.000 claims 1
- 125000006228 2-isobutoxyethyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 1
- MFCHYWIMSNKJMB-UHFFFAOYSA-N 2-methyl-5-[4-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]-1,3,4-oxadiazole Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=CC(=CC=2)C=2OC(C)=NN=2)=CC=C1[N+]([O-])=O MFCHYWIMSNKJMB-UHFFFAOYSA-N 0.000 claims 1
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims 1
- DPLLVROAWZVABY-UHFFFAOYSA-N 3-[4-[3-(4-ethoxycarbonylpiperidin-1-yl)-4-nitrophenoxy]phenyl]-2-oxopropanoic acid Chemical compound C1CC(C(=O)OCC)CCN1C1=CC(OC=2C=CC(CC(=O)C(O)=O)=CC=2)=CC=C1[N+]([O-])=O DPLLVROAWZVABY-UHFFFAOYSA-N 0.000 claims 1
- GFWQTXLDRGKEFG-UHFFFAOYSA-N 3-[4-[3-(4-ethoxycarbonylpiperidin-1-yl)-4-nitrophenoxy]phenyl]propanoic acid Chemical compound C1CC(C(=O)OCC)CCN1C1=CC(OC=2C=CC(CCC(O)=O)=CC=2)=CC=C1[N+]([O-])=O GFWQTXLDRGKEFG-UHFFFAOYSA-N 0.000 claims 1
- WWNKXJCYOXVTGI-UHFFFAOYSA-N 3-[4-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]-2-oxopropanoic acid Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=CC(CC(=O)C(O)=O)=CC=2)=CC=C1[N+]([O-])=O WWNKXJCYOXVTGI-UHFFFAOYSA-N 0.000 claims 1
- CEQVJPOYQDBGNE-UHFFFAOYSA-N 3-[4-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]propanoic acid Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=CC(CCC(O)=O)=CC=2)=CC=C1[N+]([O-])=O CEQVJPOYQDBGNE-UHFFFAOYSA-N 0.000 claims 1
- VFVIASZDGVBAEW-UHFFFAOYSA-N 3-methyl-5-[3-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]-1,2,4-oxadiazole Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=C(C=CC=2)C=2ON=C(C)N=2)=CC=C1[N+]([O-])=O VFVIASZDGVBAEW-UHFFFAOYSA-N 0.000 claims 1
- SSZRMWSKPKWIIG-UHFFFAOYSA-N 4-[4-[3-[4-(3-methyl-1,2,4-oxadiazol-5-yl)piperidin-1-yl]-4-nitrophenoxy]phenyl]butan-2-one Chemical compound C1=CC(CCC(=O)C)=CC=C1OC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)C=2ON=C(C)N=2)=C1 SSZRMWSKPKWIIG-UHFFFAOYSA-N 0.000 claims 1
- HIBOMQBOJFSMRJ-UHFFFAOYSA-N 4-[4-[3-[4-(methoxymethyl)piperidin-1-yl]-4-nitrophenoxy]phenyl]butan-2-one Chemical compound C1CC(COC)CCN1C1=CC(OC=2C=CC(CCC(C)=O)=CC=2)=CC=C1[N+]([O-])=O HIBOMQBOJFSMRJ-UHFFFAOYSA-N 0.000 claims 1
- QAQHPPBTEWEEJM-UHFFFAOYSA-N 4-[4-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]butan-2-one Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=CC(CCC(C)=O)=CC=2)=CC=C1[N+]([O-])=O QAQHPPBTEWEEJM-UHFFFAOYSA-N 0.000 claims 1
- JFIDBMRSEIBNAE-UHFFFAOYSA-N 4-[4-[4-nitro-3-(4-pyridin-2-ylsulfanylpiperidin-1-yl)phenoxy]phenyl]butan-2-one Chemical compound C1=CC(CCC(=O)C)=CC=C1OC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)SC=2N=CC=CC=2)=C1 JFIDBMRSEIBNAE-UHFFFAOYSA-N 0.000 claims 1
- YWCCANLUHWZFLR-UHFFFAOYSA-N 4-[4-[5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)pyridin-2-yl]oxyphenyl]butan-2-one Chemical compound C1=CC(CCC(=O)C)=CC=C1OC1=CC=C([N+]([O-])=O)C(N2CCC(CC2)SC=2N=CC=CC=2)=N1 YWCCANLUHWZFLR-UHFFFAOYSA-N 0.000 claims 1
- AUZWGLPRXPPHDO-UHFFFAOYSA-N 5-bromo-1-[4-nitro-3-(4-propylpiperidin-1-yl)phenyl]pyridin-2-one Chemical compound C1CC(CCC)CCN1C1=CC(N2C(C=CC(Br)=C2)=O)=CC=C1[N+]([O-])=O AUZWGLPRXPPHDO-UHFFFAOYSA-N 0.000 claims 1
- BMNJJEMCZIRGBX-UHFFFAOYSA-N 5-bromo-2-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]pyridine Chemical compound C1CC(CCC)CCN1C1=CC(OC=2N=CC(Br)=CC=2)=CC=C1[N+]([O-])=O BMNJJEMCZIRGBX-UHFFFAOYSA-N 0.000 claims 1
- HZOHXUIECWRSJH-UHFFFAOYSA-N 5-ethylsulfonyl-2-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]aniline Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C(=CC(=CC=2)S(=O)(=O)CC)N)=CC=C1[N+]([O-])=O HZOHXUIECWRSJH-UHFFFAOYSA-N 0.000 claims 1
- LDARMEAYYFGMCX-UHFFFAOYSA-N C1CC(CCC)CCN1C1=CC(OC=2C=CC(=CC=2)C2=NN(C)C(O)=C2)=CC=C1[N+]([O-])=O Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=CC(=CC=2)C2=NN(C)C(O)=C2)=CC=C1[N+]([O-])=O LDARMEAYYFGMCX-UHFFFAOYSA-N 0.000 claims 1
- 239000005973 Carvone Substances 0.000 claims 1
- GACZXTJOCSDCMT-UHFFFAOYSA-N [4-[3-[4-(methoxymethyl)piperidin-1-yl]-4-nitrophenoxy]phenyl]-phenylmethanone Chemical compound C1CC(COC)CCN1C1=CC(OC=2C=CC(=CC=2)C(=O)C=2C=CC=CC=2)=CC=C1[N+]([O-])=O GACZXTJOCSDCMT-UHFFFAOYSA-N 0.000 claims 1
- ICWUHNPSRKLUBV-UHFFFAOYSA-N [4-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]-phenylmethanone Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=CC(=CC=2)C(=O)C=2C=CC=CC=2)=CC=C1[N+]([O-])=O ICWUHNPSRKLUBV-UHFFFAOYSA-N 0.000 claims 1
- DRIFBFDYGLBJJR-UHFFFAOYSA-N [4-[[5-nitro-6-(4-pyridin-2-ylsulfanylpiperidin-1-yl)pyridin-2-yl]amino]phenyl]-phenylmethanone Chemical compound N1=C(N2CCC(CC2)SC=2N=CC=CC=2)C([N+](=O)[O-])=CC=C1NC(C=C1)=CC=C1C(=O)C1=CC=CC=C1 DRIFBFDYGLBJJR-UHFFFAOYSA-N 0.000 claims 1
- 150000001408 amides Chemical class 0.000 claims 1
- 229910052794 bromium Inorganic materials 0.000 claims 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims 1
- 229910052801 chlorine Inorganic materials 0.000 claims 1
- 238000004587 chromatography analysis Methods 0.000 claims 1
- 125000000113 cyclohexyl group Chemical group [H]C1([H])C([H])([H])C([H])([H])C([H])(*)C([H])([H])C1([H])[H] 0.000 claims 1
- 125000005448 ethoxyethyl group Chemical group [H]C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 1
- JFDVGACPVMKGDT-UHFFFAOYSA-N ethyl 1-[2-nitro-5-[4-(3-oxobutyl)phenoxy]phenyl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1C1=CC(OC=2C=CC(CCC(C)=O)=CC=2)=CC=C1[N+]([O-])=O JFDVGACPVMKGDT-UHFFFAOYSA-N 0.000 claims 1
- QYMKMUMGXJOTQI-UHFFFAOYSA-N ethyl 1-[5-(2-amino-4-ethylsulfonylphenoxy)-2-nitrophenyl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1C1=CC(OC=2C(=CC(=CC=2)S(=O)(=O)CC)N)=CC=C1[N+]([O-])=O QYMKMUMGXJOTQI-UHFFFAOYSA-N 0.000 claims 1
- KZUORSGWSYEDSJ-UHFFFAOYSA-N ethyl 1-[5-(4-benzoylanilino)-2-nitrophenyl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1C1=CC(NC=2C=CC(=CC=2)C(=O)C=2C=CC=CC=2)=CC=C1[N+]([O-])=O KZUORSGWSYEDSJ-UHFFFAOYSA-N 0.000 claims 1
- VQDBDBXTCUKZLR-UHFFFAOYSA-N ethyl 1-[5-(4-benzoylphenoxy)-2-nitrophenyl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1C1=CC(OC=2C=CC(=CC=2)C(=O)C=2C=CC=CC=2)=CC=C1[N+]([O-])=O VQDBDBXTCUKZLR-UHFFFAOYSA-N 0.000 claims 1
- GAAUTBFEIAPXEA-UHFFFAOYSA-N ethyl 1-[5-(4-ethenylphenoxy)-2-nitrophenyl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1C1=CC(OC=2C=CC(C=C)=CC=2)=CC=C1[N+]([O-])=O GAAUTBFEIAPXEA-UHFFFAOYSA-N 0.000 claims 1
- ZUHWCQOSEKJJSX-UHFFFAOYSA-N ethyl 1-[5-[4-(3-methoxy-3-oxopropanoyl)phenoxy]-2-nitrophenyl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1C1=CC(OC=2C=CC(=CC=2)C(=O)CC(=O)OC)=CC=C1[N+]([O-])=O ZUHWCQOSEKJJSX-UHFFFAOYSA-N 0.000 claims 1
- KLZFDZVHELHGKK-UHFFFAOYSA-N ethyl 1-[6-[[2-bromo-4-(trifluoromethyl)phenyl]sulfonylamino]-3-nitropyridin-2-yl]piperidine-4-carboxylate Chemical compound C1CC(C(=O)OCC)CCN1C1=NC(NS(=O)(=O)C=2C(=CC(=CC=2)C(F)(F)F)Br)=CC=C1[N+]([O-])=O KLZFDZVHELHGKK-UHFFFAOYSA-N 0.000 claims 1
- 229910052731 fluorine Inorganic materials 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 125000006229 isopropoxyethyl group Chemical group [H]C([H])([H])C([H])(OC([H])([H])C([H])([H])*)C([H])([H])[H] 0.000 claims 1
- QPBAZGXESLNBNB-UHFFFAOYSA-N methyl 3-[4-[4-nitro-3-(4-propylpiperidin-1-yl)phenoxy]phenyl]-3-oxopropanoate Chemical compound C1CC(CCC)CCN1C1=CC(OC=2C=CC(=CC=2)C(=O)CC(=O)OC)=CC=C1[N+]([O-])=O QPBAZGXESLNBNB-UHFFFAOYSA-N 0.000 claims 1
- KWTBIADLTODBKF-UHFFFAOYSA-N methyl 3-[4-[5-nitro-6-(4-propylpiperidin-1-yl)pyridin-2-yl]oxyphenyl]-3-oxopropanoate Chemical compound C1CC(CCC)CCN1C1=NC(OC=2C=CC(=CC=2)C(=O)CC(=O)OC)=CC=C1[N+]([O-])=O KWTBIADLTODBKF-UHFFFAOYSA-N 0.000 claims 1
- 125000004170 methylsulfonyl group Chemical group [H]C([H])([H])S(*)(=O)=O 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
- 125000000951 phenoxy group Chemical group [H]C1=C([H])C([H])=C(O*)C([H])=C1[H] 0.000 claims 1
- 125000003170 phenylsulfonyl group Chemical group C1(=CC=CC=C1)S(=O)(=O)* 0.000 claims 1
- 125000006225 propoxyethyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])OC([H])([H])C([H])([H])* 0.000 claims 1
- UBQKCCHYAOITMY-UHFFFAOYSA-N pyridin-2-ol Chemical compound OC1=CC=CC=N1 UBQKCCHYAOITMY-UHFFFAOYSA-N 0.000 claims 1
- 125000003107 substituted aryl group Chemical group 0.000 claims 1
- 229940124530 sulfonamide Drugs 0.000 claims 1
- 150000003456 sulfonamides Chemical class 0.000 claims 1
- 125000005420 sulfonamido group Chemical group S(=O)(=O)(N*)* 0.000 claims 1
- 125000001113 thiadiazolyl group Chemical group 0.000 claims 1
- 125000004495 thiazol-4-yl group Chemical group S1C=NC(=C1)* 0.000 claims 1
- 125000000876 trifluoromethoxy group Chemical group FC(F)(F)O* 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US44978803P | 2003-02-24 | 2003-02-24 | |
| PCT/US2004/005555 WO2004076413A2 (en) | 2003-02-24 | 2004-02-23 | Phenyl- and pyridylpiperidine-derivatives as modulators of glucose metabolism |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2006518763A JP2006518763A (ja) | 2006-08-17 |
| JP2006518763A5 true JP2006518763A5 (enExample) | 2008-11-06 |
Family
ID=32927568
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2006503856A Pending JP2006518763A (ja) | 2003-02-24 | 2004-02-23 | グルコース代謝のモジュレーターとしてのフェニル−およびピリジルピペリジン誘導体 |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US20070066590A1 (enExample) |
| EP (1) | EP1606282B1 (enExample) |
| JP (1) | JP2006518763A (enExample) |
| KR (1) | KR20050106033A (enExample) |
| CN (1) | CN1751038A (enExample) |
| AT (1) | ATE414076T1 (enExample) |
| AU (1) | AU2004215344B2 (enExample) |
| BR (1) | BRPI0407620A (enExample) |
| CA (1) | CA2515963A1 (enExample) |
| CY (1) | CY1108736T1 (enExample) |
| DE (1) | DE602004017703D1 (enExample) |
| DK (1) | DK1606282T3 (enExample) |
| EA (1) | EA200501348A1 (enExample) |
| ES (1) | ES2316964T3 (enExample) |
| MX (1) | MXPA05007614A (enExample) |
| PL (1) | PL378295A1 (enExample) |
| PT (1) | PT1606282E (enExample) |
| SI (1) | SI1606282T1 (enExample) |
| WO (1) | WO2004076413A2 (enExample) |
Families Citing this family (107)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR2817257B1 (fr) | 2000-11-30 | 2009-03-20 | Sanofi Synthelabo | Cyclohexyl(alkyl)-propanolamines, leur preparation et compositions pharmaceutiques en contenant |
| KR101078098B1 (ko) | 2003-01-14 | 2011-10-28 | 아레나 파마슈티칼스, 인크. | 대사 조절제로서의 １,２,３-삼치환된 아릴 및 헤테로아릴유도체, 및 당뇨병 및 고혈당증을 비롯한 이에 관련된장애의 예방 및 치료 |
| AR045047A1 (es) | 2003-07-11 | 2005-10-12 | Arena Pharm Inc | Derivados arilo y heteroarilo trisustituidos como moduladores del metabolismo y de la profilaxis y tratamiento de desordenes relacionados con los mismos |
| MX2007003327A (es) | 2004-09-20 | 2007-06-05 | Xenon Pharmaceuticals Inc | Derivados heterociclicos, y su uso como mediadores de estearoil-coa desaturasa. |
| BRPI0515482A (pt) | 2004-09-20 | 2008-07-22 | Xenon Pharmaceuticals Inc | derivados heterocìclicos e seus usos como agentes terapêuticos |
| TW200626138A (en) | 2004-09-20 | 2006-08-01 | Xenon Pharmaceuticals Inc | Heterocyclic derivatives and their use as therapeutic agents |
| AR051026A1 (es) | 2004-09-20 | 2006-12-13 | Xenon Pharmaceuticals Inc | Derivados heterociclicos y su uso como inhibidores de la estearoil-coa desaturasa |
| US8071603B2 (en) | 2004-09-20 | 2011-12-06 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors |
| CA2580855A1 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Heterocyclic derivatives and their use as stearoyl-coa desaturase inhibitors |
| WO2006034341A2 (en) | 2004-09-20 | 2006-03-30 | Xenon Pharmaceuticals Inc. | Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase |
| CA2582276C (en) * | 2004-10-04 | 2011-09-13 | F. Hoffmann-La Roche Ag | Alkil-pyridines as 11-beta inhibitors for diabetes |
| NZ556017A (en) * | 2004-12-24 | 2009-10-30 | Prosidion Ltd | G-protein coupled receptor (gpr116) agonists and use thereof for treating obesity and diabetes |
| DOP2006000008A (es) * | 2005-01-10 | 2006-08-31 | Arena Pharm Inc | Terapia combinada para el tratamiento de la diabetes y afecciones relacionadas y para el tratamiento de afecciones que mejoran mediante un incremento de la concentración sanguínea de glp-1 |
| DOP2006000010A (es) * | 2005-01-10 | 2006-07-31 | Arena Pharm Inc | Procedimiento para preparar eteres aromáticos |
| MY148521A (en) * | 2005-01-10 | 2013-04-30 | Arena Pharm Inc | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
| WO2006106423A2 (en) * | 2005-04-07 | 2006-10-12 | Pfizer Inc. | Amino sulfonyl derivatives as inhibitors of human 11-.beta.-hydrosysteroid dehydrogenase |
| US8541457B2 (en) | 2005-06-03 | 2013-09-24 | Xenon Pharmaceuticals Inc. | Aminothiazole derivatives as human stearoyl-CoA desaturase inhibitors |
| EP1931654B1 (en) * | 2005-09-16 | 2009-04-22 | Arena Pharmaceuticals, Inc. | Modulators of metabolism and the treatment of disorders related thereto |
| AR059898A1 (es) | 2006-03-15 | 2008-05-07 | Janssen Pharmaceutica Nv | Derivados de 3-ciano-piridona 1,4-disustituida y su uso como moduladores alostericos de los receptores mglur2 |
| PE20080176A1 (es) | 2006-03-31 | 2008-04-25 | Glaxo Group Ltd | Compuestos de arilpiperazina sulfonamida como agonista de los receptores de secretagogos de la hormona de crecimiento (ghs) |
| BRPI0710597A2 (pt) * | 2006-04-11 | 2012-06-19 | Arena Pharm Inc | método de uso do receptor gpr119 para identificar compostos úteis para aumento da massa óssea em um indivìduo |
| PE20071221A1 (es) | 2006-04-11 | 2007-12-14 | Arena Pharm Inc | Agonistas del receptor gpr119 en metodos para aumentar la masa osea y para tratar la osteoporosis y otras afecciones caracterizadas por masa osea baja, y la terapia combinada relacionada a estos agonistas |
| TW200811140A (en) * | 2006-07-06 | 2008-03-01 | Arena Pharm Inc | Modulators of metabolism and the treatment of disorders related thereto |
| TW200811147A (en) * | 2006-07-06 | 2008-03-01 | Arena Pharm Inc | Modulators of metabolism and the treatment of disorders related thereto |
| CN101511429A (zh) * | 2006-07-13 | 2009-08-19 | 史密丝克莱恩比彻姆公司 | 二氢吲哚衍生物和gpr119激动剂 |
| EP2112880A4 (en) | 2006-12-14 | 2011-12-21 | Merck Sharp & Dohme | ACYLBIPIPERIDINYL COMPOUNDS, COMPOSITIONS CONTAINING SUCH COMPOUNDS AND TREATMENT METHOD |
| US7638541B2 (en) | 2006-12-28 | 2009-12-29 | Metabolex Inc. | 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine |
| TW200900065A (en) | 2007-03-07 | 2009-01-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-pyridinyloxy-phenyl)-pyridin-2-one derivatives |
| TW200845978A (en) | 2007-03-07 | 2008-12-01 | Janssen Pharmaceutica Nv | 3-cyano-4-(4-tetrahydropyran-phenyl)-pyridin-2-one derivatives |
| JP5550352B2 (ja) | 2007-03-15 | 2014-07-16 | ノバルティス アーゲー | 有機化合物およびその使用 |
| CN102015677A (zh) * | 2007-04-20 | 2011-04-13 | 先灵公司 | 嘧啶酮衍生物及其使用方法 |
| MX2009011359A (es) * | 2007-04-20 | 2009-11-05 | Schering Corp | Derivados de pirimidinona y sus metodos de uso. |
| PE20090213A1 (es) | 2007-05-04 | 2009-02-28 | Bristol Myers Squibb Co | Agonistas del receptor acoplado a la proteina g gpr119 [6,5]-biciclicos |
| WO2008137435A1 (en) | 2007-05-04 | 2008-11-13 | Bristol-Myers Squibb Company | [6,6] and [6,7]-bicyclic gpr119 g protein-coupled receptor agonists |
| EA018709B1 (ru) | 2007-07-17 | 2013-10-30 | Бристол-Маерс Сквибб Компани | Пиридоновые агонисты сопряженного с g-белком рецептора gpr119 |
| CA2693169C (en) * | 2007-07-19 | 2016-01-12 | Metabolex, Inc. | N-linked heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders |
| BRPI0817101A2 (pt) | 2007-09-14 | 2017-05-09 | Addex Pharmaceuticals Sa | 4-(aril-x-fenil)-1h-piridin-2-onas 1,3-dissubstituídas |
| ES2409215T3 (es) | 2007-09-14 | 2013-06-25 | Janssen Pharmaceuticals, Inc. | 4-fenil-1H-piridin-2-onas 1-3-disustituidas |
| SI2203439T1 (sl) | 2007-09-14 | 2011-05-31 | Ortho Mcneil Janssen Pharm | 1',3'-disubstituirani 4-fenil-3,4,5,6-tetrahidro-2H-1'H-(1,4')bipiridinil-2'-oni |
| AU2008302570B2 (en) | 2007-09-20 | 2012-05-31 | Irm Llc | Compounds and compositions as modulators of GPR119 activity |
| KR20100075643A (ko) | 2007-10-22 | 2010-07-02 | 쉐링 코포레이션 | 비사이클릭 헤테로사이클 유도체 및 ｇｐｒ119의 활성의 조절인자로서의 이의 용도 |
| ES2637794T3 (es) | 2007-11-14 | 2017-10-17 | Janssen Pharmaceuticals, Inc. | Derivados de imidazo[1,2-A]piridina y su uso como moduladores alostéricos positivos de receptores MGLUR2 |
| EP2108960A1 (en) | 2008-04-07 | 2009-10-14 | Arena Pharmaceuticals, Inc. | Methods of using A G protein-coupled receptor to identify peptide YY (PYY) secretagogues and compounds useful in the treatment of conditons modulated by PYY |
| CA2724426A1 (en) | 2008-05-19 | 2009-11-26 | Schering Corporation | Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
| EP2324036B1 (en) | 2008-07-16 | 2014-12-03 | Merck Sharp & Dohme Corp. | Bicyclic heterocycle derivatives and methods of use thereof |
| TW201006821A (en) | 2008-07-16 | 2010-02-16 | Bristol Myers Squibb Co | Pyridone and pyridazone analogues as GPR119 modulators |
| EP2318404B1 (en) | 2008-07-16 | 2013-08-21 | Merck Sharp & Dohme Corp. | Bicyclic heterocycle derivatives and use thereof as gpr119 modulators |
| US20100041663A1 (en) | 2008-07-18 | 2010-02-18 | Novartis Ag | Organic Compounds as Smo Inhibitors |
| EP2311822A4 (en) | 2008-08-01 | 2011-08-31 | Nippon Chemiphar Co | GPR119 AGONIST |
| ES2439291T3 (es) | 2008-09-02 | 2014-01-22 | Janssen Pharmaceuticals, Inc. | Derivados de 3-azabiciclo[3.1.0]hexilo como moduladores de receptores de glutamato metabotrópicos |
| CA2738849C (en) | 2008-10-16 | 2016-06-28 | Addex Pharma S.A. | Indole and benzomorpholine derivatives as modulators of metabotropic glutamate receptors |
| ES2401691T3 (es) | 2008-11-28 | 2013-04-23 | Ortho-Mcneil-Janssen Pharmaceuticals, Inc. | Derivados de indol y de benzoxacina como moduladores de los receptores metabotrópicos de glutamato |
| US8722882B2 (en) | 2008-12-23 | 2014-05-13 | Merck Sharp & Dohme Corp. | Pyrimidine derivatives as GPCR modulators for use in the treatment of obesity and diabetes |
| WO2010075273A1 (en) | 2008-12-23 | 2010-07-01 | Schering Corporation | Bicyclic heterocycle derivatives and methods of use thereof |
| US8410122B2 (en) | 2008-12-23 | 2013-04-02 | Merck Sharp & Dohme Corp. | Bicyclic heterocycle derivatives and methods of use thereof |
| AR076024A1 (es) | 2009-04-03 | 2011-05-11 | Schering Corp | Derivados de heterociclos biciclicos puenteados y metodos de uso de los mismos |
| US8580807B2 (en) | 2009-04-03 | 2013-11-12 | Merck Sharp & Dohme Corp. | Bicyclic piperidine and piperazine derivatives as GPCR modulators for the treatment of obesity, diabetes and other metabolic disorders |
| MY153913A (en) | 2009-05-12 | 2015-04-15 | Janssen Pharmaceuticals Inc | 7-aryl-1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| SG176018A1 (en) | 2009-05-12 | 2011-12-29 | Janssen Pharmaceuticals Inc | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| ES2440001T3 (es) | 2009-05-12 | 2014-01-27 | Janssen Pharmaceuticals, Inc. | Derivados de 1,2,4-triazolo[4,3-A]piridina y su uso para el tratamiento o prevención de trastornos neurológicos y psiquiátricos |
| AR077642A1 (es) | 2009-07-09 | 2011-09-14 | Arena Pharm Inc | Moduladores del metabolismo y el tratamiento de trastornos relacionados con el mismo |
| EP2474540A4 (en) | 2009-08-31 | 2013-03-13 | Nippon Chemiphar Co | GPR119 AGONIST |
| CN102666553B (zh) | 2009-10-01 | 2015-05-06 | 赛马拜制药公司 | 取代的四唑-1-基-苯氧基甲基-噻唑-2-基-哌啶基-嘧啶盐 |
| US9409918B2 (en) | 2009-10-29 | 2016-08-09 | Merck Sharp & Dohme Corp. | Bridged bicyclic piperidine derivatives and methods of use thereof |
| US20120232073A1 (en) | 2009-11-23 | 2012-09-13 | Santhosh Francis Neelamkavil | Fused bicyclic pyrimidine derivatives and methods of use thereof |
| US8912206B2 (en) | 2009-11-23 | 2014-12-16 | Merck Sharp & Dohme Corp. | Pyrimidine ether derivatives and methods of use thereof |
| WO2011066137A1 (en) | 2009-11-24 | 2011-06-03 | Schering Corporation | Substituted biaryl derivatives and methods of use thereof |
| CN108558740B (zh) | 2010-01-27 | 2021-10-19 | 艾尼纳制药公司 | S1p1受体调节剂及其盐的制备方法 |
| WO2011113947A1 (en) | 2010-03-18 | 2011-09-22 | Boehringer Ingelheim International Gmbh | Combination of a gpr119 agonist and the dpp-iv inhibitor linagliptin for use in the treatment of diabetes and related conditions |
| WO2011127051A1 (en) | 2010-04-06 | 2011-10-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| MX2012011460A (es) | 2010-04-08 | 2012-11-23 | Squibb Bristol Myers Co | Analogos de pirimidinilpiperidiniloxipiridinona como moduladores de gpr119. |
| EA201270778A1 (ru) | 2010-05-06 | 2013-04-30 | Бристол-Майерс Сквибб Компани | Бициклические гетероарильные аналоги в качестве модуляторов рецептора gpr119 |
| WO2011140161A1 (en) | 2010-05-06 | 2011-11-10 | Bristol-Myers Squibb Company | Benzofuranyl analogues as gpr119 modulators |
| WO2012025811A1 (en) | 2010-08-23 | 2012-03-01 | Lupin Limited | Indolylpyrimidines as modulators of gpr119 |
| SG188548A1 (en) | 2010-09-22 | 2013-04-30 | Arena Pharm Inc | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| CA2814998C (en) | 2010-11-08 | 2019-10-29 | Janssen Pharmaceuticals, Inc. | 1,2,4-triazolo[4,3-a]pyridine derivatives and their use as positive allosteric modulators of mglur2 receptors |
| ES2552455T3 (es) | 2010-11-08 | 2015-11-30 | Janssen Pharmaceuticals, Inc. | Derivados de 1,2,4-triazolo[4,3-a]piridina y su uso como moduladores alostéricos positivos de receptores mGluR2 |
| CN103298809B (zh) | 2010-11-08 | 2016-08-31 | 杨森制药公司 | 1,2,4-三唑并[4,3-a]吡啶衍生物及其作为MGLUR2受体的正变构调节剂的用途 |
| CA2818050A1 (en) | 2010-11-26 | 2012-05-31 | Lupin Limited | Bicyclic gpr119 modulators |
| JP2014094886A (ja) * | 2011-02-28 | 2014-05-22 | Nippon Chemiphar Co Ltd | Ｇｐｒ１１９作動薬 |
| WO2012135570A1 (en) | 2011-04-01 | 2012-10-04 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| US20140066369A1 (en) | 2011-04-19 | 2014-03-06 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
| US20140038889A1 (en) | 2011-04-22 | 2014-02-06 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
| US20140051714A1 (en) | 2011-04-22 | 2014-02-20 | Arena Pharmaceuticals, Inc. | Modulators Of The GPR119 Receptor And The Treatment Of Disorders Related Thereto |
| WO2012170702A1 (en) | 2011-06-08 | 2012-12-13 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| WO2012170867A1 (en) | 2011-06-09 | 2012-12-13 | Rhizen Pharmaceuticals Sa | Novel compounds as modulators of gpr-119 |
| WO2013055910A1 (en) | 2011-10-12 | 2013-04-18 | Arena Pharmaceuticals, Inc. | Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| EP2850073B1 (en) | 2012-05-16 | 2017-07-19 | Bristol-Myers Squibb Company | Pyrimidinylpiperidinyloxypyridone analogues as gpr119 modulators |
| WO2014074668A1 (en) | 2012-11-08 | 2014-05-15 | Arena Pharmaceuticals, Inc. | Modulators of gpr119 and the treatment of disorders related thereto |
| JO3368B1 (ar) | 2013-06-04 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 6، 7- ثاني هيدرو بيرازولو [5،1-a] بيرازين- 4 (5 يد)- اون واستخدامها بصفة منظمات تفارغية سلبية لمستقبلات ميجلور 2 |
| JO3367B1 (ar) | 2013-09-06 | 2019-03-13 | Janssen Pharmaceutica Nv | مركبات 2،1، 4- ثلاثي زولو [3،4-a] بيريدين واستخدامها بصفة منظمات تفارغية موجبة لمستقبلات ميجلور 2 |
| IL279202B2 (en) | 2014-01-21 | 2023-09-01 | Janssen Pharmaceutica Nv | Combinations containing positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic subtype 2 receptor and their use |
| US10537573B2 (en) | 2014-01-21 | 2020-01-21 | Janssen Pharmaceutica Nv | Combinations comprising positive allosteric modulators or orthosteric agonists of metabotropic glutamatergic receptor subtype 2 and their use |
| PL3242666T3 (pl) | 2015-01-06 | 2025-02-17 | Arena Pharmaceuticals, Inc. | Związek do zastosowania w leczeniu dolegliwości związanych z receptorem s1p1 |
| CN104610143A (zh) * | 2015-02-12 | 2015-05-13 | 佛山市赛维斯医药科技有限公司 | 一种含硝基喹啉结构的葡萄糖激酶活化剂及其用途 |
| CN104557695A (zh) * | 2015-02-12 | 2015-04-29 | 佛山市赛维斯医药科技有限公司 | 含喹啉结构的葡萄糖激酶活化剂、制备方法及其用途 |
| CN104592113A (zh) * | 2015-02-12 | 2015-05-06 | 佛山市赛维斯医药科技有限公司 | 含喹啉和腈基苯结构的葡萄糖激酶活化剂及用途 |
| CN106749010A (zh) * | 2015-02-12 | 2017-05-31 | 佛山市赛维斯医药科技有限公司 | 一类含喹啉和硝基苯结构的葡萄糖激酶活化剂及用途 |
| CN104557698A (zh) * | 2015-02-12 | 2015-04-29 | 佛山市赛维斯医药科技有限公司 | 含喹啉基和烷氧苯基结构的葡萄糖激酶活化剂及用途 |
| CN104892505A (zh) * | 2015-02-12 | 2015-09-09 | 佛山市赛维斯医药科技有限公司 | 含卤代喹啉结构的葡萄糖激酶活化剂、制备方法及其用途 |
| CN106800532A (zh) * | 2015-02-12 | 2017-06-06 | 佛山市赛维斯医药科技有限公司 | 一种含腈基喹啉结构的葡萄糖激酶活化剂及其用途 |
| HUE060476T2 (hu) | 2015-06-22 | 2023-03-28 | Arena Pharm Inc | (R)-2-(7-(4-ciklopentil-3-(trifluormetil)benziloxi)-1,2,3,4- tetrahidrociklopenta[B]indol-3-il)ecetsav kristályos L-arginin-sója S1P1 receptorral kapcsolatos rendellenességek esetén való alkalmazásra |
| JP2019527693A (ja) | 2016-08-03 | 2019-10-03 | サイマベイ・セラピューティクス・インコーポレイテッドＣｙｍａＢａｙ Ｔｈｅｒａｐｅｕｔｉｃｓ，Ｉｎｃ． | 炎症性胃腸疾患または胃腸状態を治療するためのオキシメチレンアリール化合物 |
| WO2018151873A1 (en) | 2017-02-16 | 2018-08-23 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of primary biliary cholangitis |
| MA49456A (fr) | 2017-06-19 | 2020-04-29 | Arena Pharm Inc | Composés et procédés pour le traitement de nafld et de nash |
| CN107007849A (zh) * | 2017-06-19 | 2017-08-04 | 河北省人民医院 | 一种建立甲减性心功能不全大鼠动物模型的方法 |
| US12156866B2 (en) | 2018-06-06 | 2024-12-03 | Arena Pharmaceuticals, Inc. | Methods of treating conditions related to the S1P1 receptor |
Family Cites Families (39)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CH478817A (de) * | 1965-10-22 | 1969-09-30 | Ciba Geigy | Verfahren zur Herstellung neuer N,N'-Di-(pyrimidyl-(4)-aminoalkyl)-diazacycloalkanen |
| CA961052A (en) * | 1967-01-12 | 1975-01-14 | Max Schellenbaum | N-2-ethylhexyl-n'-aryl ureas and preparation containing them |
| US3608087A (en) * | 1968-06-21 | 1971-09-21 | Merck & Co Inc | Feed compositions |
| US3887329A (en) * | 1969-05-05 | 1975-06-03 | Ciba Geigy Ag | Hexamethyl phosphotriamide-dye compositions |
| US3686238A (en) * | 1970-01-19 | 1972-08-22 | Syntex Corp | Glycerol esterified with 2-naphthyl-acetic acids and fatty acids |
| US3852434A (en) * | 1970-09-11 | 1974-12-03 | Merck & Co Inc | Potentiation of ({31 ) cis-1,2-epoxypropyl)phosphonic acid and analogues thereof |
| US3966744A (en) * | 1971-01-11 | 1976-06-29 | Syva Company | Spin labeled compounds |
| US3690834A (en) * | 1971-01-11 | 1972-09-12 | Syva Co | Ligand determination with spin labeled compounds by receptor displacement |
| DE2106585A1 (de) * | 1971-02-11 | 1972-08-24 | Farbenfabriken Bayer Ag, 5090 Leverkusen | Aminothiodiazole und Thiodiazol-Azofarbstoffe |
| US3966764A (en) * | 1972-07-10 | 1976-06-29 | Syva Company | Ligand determination of spin labeled compounds by receptor displacement-amphetamine analogs |
| US3849420A (en) * | 1972-10-20 | 1974-11-19 | Dow Chemical Co | Bis-(alkylthio-and alkylsulfonyl)-pentachloroquinolines |
| DE2340569C2 (de) * | 1973-08-10 | 1982-12-02 | Bayer Ag, 5090 Leverkusen | Azofarbstoffe |
| AT340933B (de) * | 1973-08-20 | 1978-01-10 | Thomae Gmbh Dr K | Verfahren zur herstellung neuer pyrimidinderivate und ihrer saureadditionssalze |
| US4101541A (en) * | 1973-12-21 | 1978-07-18 | Ciba-Geigy Corporation | 3-Cyano-1,2,4-thiadiazolyl-5-czo dyestuffs |
| FR2306697A1 (fr) * | 1975-04-10 | 1976-11-05 | Sogeras | Nouvelles pyrimidines utilisables comme medicaments antidiabetiques et hypocholesterolemiants |
| DE2731264A1 (de) * | 1977-07-11 | 1979-02-01 | Boehringer Mannheim Gmbh | Neue 1-acyl-2-cyanaziridine, verfahren zu deren herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen |
| JPS6038696B2 (ja) * | 1977-12-09 | 1985-09-02 | コニカ株式会社 | ハロゲン化銀カラ−写真感光材料 |
| US4242507A (en) * | 1978-02-23 | 1980-12-30 | Fujisawa Pharmaceutical Co., Ltd. | Sulfonic acid esters |
| DE2906603A1 (de) * | 1979-02-21 | 1980-09-04 | Boehringer Mannheim Gmbh | N-substituierte aziridin-2-carbonsaeurederivate, verfahren zu deren herstellung sowie diese substanzen enthaltende arzneimittel |
| DE4241632A1 (de) * | 1992-12-10 | 1994-06-16 | Thomae Gmbh Dr K | Carbonsäurederivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung |
| TW574214B (en) * | 1994-06-08 | 2004-02-01 | Pfizer | Corticotropin releasing factor antagonists |
| US5691364A (en) * | 1995-03-10 | 1997-11-25 | Berlex Laboratories, Inc. | Benzamidine derivatives and their use as anti-coagulants |
| US6956047B1 (en) * | 1995-06-06 | 2005-10-18 | Pfizer Inc. | Corticotropin releasing factor antagonists |
| US6403599B1 (en) * | 1995-11-08 | 2002-06-11 | Pfizer Inc | Corticotropin releasing factor antagonists |
| US5849759A (en) * | 1995-12-08 | 1998-12-15 | Berlex Laboratories, Inc. | Naphthyl-substituted benzimidazole derivatives as anti-coagulants |
| US5948786A (en) * | 1996-04-12 | 1999-09-07 | Sumitomo Pharmaceuticals Company, Limited | Piperidinylpyrimidine derivatives |
| AR008789A1 (es) * | 1996-07-31 | 2000-02-23 | Bayer Corp | Piridinas y bifenilos substituidos |
| US6008234A (en) * | 1996-09-12 | 1999-12-28 | Berlex Laboratories, Inc. | Benzamidine derivatives substituted by cyclic amino acid and cyclic hydroxy acid derivatives and their use as anti-coagulants |
| ZA981029B (en) * | 1997-02-11 | 1999-08-10 | Lilly Co Eli | Pharmaceutical agents. |
| US6187777B1 (en) * | 1998-02-06 | 2001-02-13 | Amgen Inc. | Compounds and methods which modulate feeding behavior and related diseases |
| AU3123500A (en) * | 1998-12-17 | 2000-07-03 | American Home Products Corporation | Arylpiperidine and aryl-1,2,5,6-tetrahydropyridine urea derivatives having 5ht1areceptor activity |
| US6239126B1 (en) * | 1998-12-17 | 2001-05-29 | American Home Products Corporation | Arylpiperidine and aryl-1,2,5,6-tetra-hydropyridine urea derivatives |
| US6414002B1 (en) * | 1999-09-22 | 2002-07-02 | Bristol-Myers Squibb Company | Substituted acid derivatives useful as antidiabetic and antiobesity agents and method |
| US6525064B1 (en) * | 2000-12-08 | 2003-02-25 | 3M Innovative Properties Company | Sulfonamido substituted imidazopyridines |
| US6545017B1 (en) * | 2000-12-08 | 2003-04-08 | 3M Innovative Properties Company | Urea substituted imidazopyridines |
| US6545016B1 (en) * | 2000-12-08 | 2003-04-08 | 3M Innovative Properties Company | Amide substituted imidazopyridines |
| KR101078098B1 (ko) * | 2003-01-14 | 2011-10-28 | 아레나 파마슈티칼스, 인크. | 대사 조절제로서의 １,２,３-삼치환된 아릴 및 헤테로아릴유도체, 및 당뇨병 및 고혈당증을 비롯한 이에 관련된장애의 예방 및 치료 |
| US7083933B1 (en) * | 2003-05-09 | 2006-08-01 | Prosidion Limited | Methods for identification of modulators of OSGPR116 activity |
| MY148521A (en) * | 2005-01-10 | 2013-04-30 | Arena Pharm Inc | Substituted pyridinyl and pyrimidinyl derivatives as modulators of metabolism and the treatment of disorders related thereto |
-
2004
- 2004-02-23 CA CA002515963A patent/CA2515963A1/en not_active Withdrawn
- 2004-02-23 WO PCT/US2004/005555 patent/WO2004076413A2/en not_active Ceased
- 2004-02-23 DE DE602004017703T patent/DE602004017703D1/de not_active Expired - Lifetime
- 2004-02-23 DK DK04713803T patent/DK1606282T3/da active
- 2004-02-23 PT PT04713803T patent/PT1606282E/pt unknown
- 2004-02-23 BR BRPI0407620-6A patent/BRPI0407620A/pt not_active IP Right Cessation
- 2004-02-23 AU AU2004215344A patent/AU2004215344B2/en not_active Ceased
- 2004-02-23 ES ES04713803T patent/ES2316964T3/es not_active Expired - Lifetime
- 2004-02-23 MX MXPA05007614A patent/MXPA05007614A/es active IP Right Grant
- 2004-02-23 CN CNA2004800044127A patent/CN1751038A/zh active Pending
- 2004-02-23 KR KR1020057015582A patent/KR20050106033A/ko not_active Ceased
- 2004-02-23 US US10/546,665 patent/US20070066590A1/en not_active Abandoned
- 2004-02-23 EP EP04713803A patent/EP1606282B1/en not_active Expired - Lifetime
- 2004-02-23 PL PL378295A patent/PL378295A1/pl not_active Application Discontinuation
- 2004-02-23 AT AT04713803T patent/ATE414076T1/de active
- 2004-02-23 SI SI200431030T patent/SI1606282T1/sl unknown
- 2004-02-23 EA EA200501348A patent/EA200501348A1/ru unknown
- 2004-02-23 JP JP2006503856A patent/JP2006518763A/ja active Pending
-
2009
- 2009-01-29 CY CY20091100109T patent/CY1108736T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2006518763A5 (enExample) | ||
| JP2010513397A5 (enExample) | ||
| JP2013507366A5 (enExample) | ||
| JP5501226B2 (ja) | アリールスルホニル誘導体を有効成分とする長鎖脂肪酸伸長酵素阻害剤 | |
| TWI358409B (en) | Heteroaryl substituted piperidine derivatives | |
| JP2002507968A (ja) | 中性のＰ１特異性基を有するＸａ因子阻害剤 | |
| JP5036316B2 (ja) | アリールオキシ置換ベンズイミダゾール誘導体 | |
| JP2009537543A5 (enExample) | ||
| NZ609955A (en) | Sgc stimulators | |
| JP2006518763A (ja) | グルコース代謝のモジュレーターとしてのフェニル−およびピリジルピペリジン誘導体 | |
| HRP20120240T1 (hr) | Piridil piperidin antagonisti receptora za oreksin | |
| TW201038586A (en) | Sulfonamide derivatives | |
| NZ596071A (en) | Oxazole substituted indazoles as pi3-kinase inhibitors | |
| JP2010513272A5 (enExample) | ||
| JP2006516572A5 (enExample) | ||
| JP2012517479A5 (enExample) | ||
| CN1617850A (zh) | 二苄胺化合物及其药物用途 | |
| EP2350006A1 (en) | Compounds for inflammation and immune-related uses | |
| JP2016519156A5 (enExample) | ||
| JP2004504301A5 (enExample) | ||
| JP2006516572A (ja) | 代謝モジュレーターとしての１，２，３−トリ置換アリール誘導体および１，２，３−トリ置換ヘテロアリール誘導体ならびにこれらの誘導体に関連する糖尿病および高血糖のような障害の予防および処置 | |
| JP2007531752A5 (enExample) | ||
| TW200539854A (en) | Compounds, pharmaceutical compositions and methods for use in treating metabolic disorders | |
| JP2007511485A5 (enExample) | ||
| JP2007519754A5 (enExample) |